Ipca Laboratories: Board Meeting Intimation for Unaudited Standalone And Consolidated Financial Results For The 2Nd Quarter And Half Year Ended 30Th September 2022 And Interim Dividend | Value Research

Ipca Laboratories: Board Meeting Intimation for Unaudited Standalone And Consolidated Financial Results For The 2Nd Quarter And Half Year Ended 30Th September 2022 And Interim Dividend

IPCA LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/11/2022 inter alia to consider and approve the Standalone and Consolidated Unaudited Financial Results for the 2nd quarter and half year ended 30th September 2022; and to consider declaration of Interim Dividend for the financial year 2022-23.

Click here to view PDF


Other Categories